Katlyn Borgers

Journal Article
A1
open access

Exploration of synergistic action of cell wall-degrading enzymes against mycobacterium tuberculosis

Loes van Schie (UGent) , Katlyn Borgers, Gitte Michielsen (UGent) , Evelyn Plets (UGent) , Marnik Vuylsteke, Petra Tiels (UGent) , Nele Festjens (UGent) and Nico Callewaert (UGent)

(2021) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 65(10).

Add to list

Journal Article
A1
open access

Development of a counterselectable transposon to create markerless knockouts from an 18,432-clone ordered Mycobacterium bovis bacillus Calmette-Guérin mutant resource

Katlyn Borgers, Kristof Vandewalle, Annelies Van Hecke (UGent) , Gitte Michielsen (UGent) , Evelyn Plets (UGent) , Loes van Schie (UGent) , Sandrine Vanmarcke (UGent) , Laurent Schindfessel (UGent) , Nele Festjens (UGent) and Nico Callewaert (UGent)

(2020) MSYSTEMS. 5(4).

Add to list

Journal Article
A1
open access

Reference genome and comparative genome analysis for the WHO reference strain for Mycobacterium bovis BCG Danish, the present tuberculosis vaccine

Katlyn Borgers, Jheng-Yang Ou, Po-Xing Zheng, Petra Tiels (UGent) , Annelies Van Hecke (UGent) , Evelyn Plets (UGent) , Gitte Michielsen (UGent) , Nele Festjens (UGent) , Nico Callewaert (UGent) and Yao-Cheng Lin

(2019) BMC GENOMICS. 20.

Add to list

A guide to Mycobacterium mutagenesis

Katlyn Borgers, Kristof Vandewalle, Nele Festjens (UGent) and Nico Callewaert (UGent)

(2019) FEBS JOURNAL. 286(19). p.3757-3774

Add to list

SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization

Nele Festjens (UGent) , Kristof Vandewalle, Erica Houthuys (UGent) , Evelyn Plets (UGent) , Dieter Vanderschaeghe (UGent) , Katlyn Borgers, Annelies Van Hecke (UGent) , Petra Tiels (UGent) and Nico Callewaert (UGent)

(2019) VACCINE. 37(27). p.3539-3551

Add to list

PhD Thesis
open access

Development and implementation of novel genetic tools for slow-growing mycobacteria

Katlyn Borgers

(2019)

Academic Bibliography

Katlyn Borgers

Exploration of synergistic action of cell wall-degrading enzymes against mycobacterium tuberculosis

Development of a counterselectable transposon to create markerless knockouts from an 18,432-clone ordered Mycobacterium bovis bacillus Calmette-Guérin mutant resource

Reference genome and comparative genome analysis for the WHO reference strain for Mycobacterium bovis BCG Danish, the present tuberculosis vaccine

A guide to Mycobacterium mutagenesis

SapM mutation to improve the BCG vaccine : genomic, transcriptomic and preclinical safety characterization

Development and implementation of novel genetic tools for slow-growing mycobacteria

Contents

Support

Contact